Moreover, the antitumor effect of type I IFN signaling is well described and B16-F10 tumors grafted on IFNAR-/- presented an increased tumor development compared to WT (35) as we also demonstrated in Figure 3C. The gene discussed is IFNAR1; the disease is neoplasm.